DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders

Free Radical Biology and Medicine

Volumn 47, Issue 10, 2009, Pages 1354-1361

  Kahle, Philipp J ^a   Waak, Jens ^a   Gasser, Thomas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

DJ 1; Free radicals; Neurodegeneration; Parkinson's disease; Redox signaling

Indexed keywords

DJ 1 PROTEIN; REACTIVE OXYGEN METABOLITE;

AGING; ANIMAL CELL; ANIMAL TISSUE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEGENERATIVE DISEASE; DISEASE MARKER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

PARKINSONIA;

EID: 70350002152     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.08.003     Document Type: Review

References (124)

1. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S.M.M., and Ariga H. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 231 (1997) 509-513
2. Kim R.H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G.C., DeLuca C., Liepa J., Zhou L., Snow B., Binari R.C., Manoukian A.S., Bray M.R., Liu F.-F., Tsao M.S., and Mak T.W. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7 (2005) 263-273
3. Liu H., Wang M., Li M., Wang D., Rao Q., Wang Y., Xu Z., and Wang J. Expression and role of DJ-1 in leukemia. Biochem. Biophys. Res. Commun. 375 (2008) 477-483
4. Le Naour F., Misek D.E., Krause M.C., Deneux L., Giordano T.J., Scholl S., and Hanash S.M. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 7 (2001) 3328-3335
5. Pardo M., García A., Thomas B., Piñeiro A., Akoulitchev A., Dwek R.A., and Zitzmann N. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int. J. Cancer 119 (2006) 1014-1022
6. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C.J., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299 (2003) 256-259
7. Görner K., Holtorf E., Odoy S., Nuscher B., Yamamoto A., Regula J.T., Beyer K., Haass C., and Kahle P.J. Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. J. Biol. Chem 279 (2004) 6943-6951
8. L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. Hum. Mol. Genet. 12 (2003) 2807-2816
9. Miller D.W., Ahmad R., Hague S., Baptista M.J., Canet-Avilés R., McLendon C., Carter D.M., Zhu P.-P., Stadler J., Chandran J., Klinefelter G.R., Blackstone C., Cookson M.R., and mutant DJ-1 L. causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J. Biol. Chem 278 (2003) 36588-36595
10. Moore D.J., Zhang L., Dawson T.M., and Dawson V.L. A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J. Neurochem. 87 (2003) 1558-1567
11. Olzmann J.A., Brown K., Wilkinson K.D., Rees H.D., Huai Q., Ke H., Levey A.I., Li L., and Chin L.-S. Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J. Biol. Chem. 279 (2004) 8506-8515
12. Abou-Sleiman P.M., Healy D.G., Quinn N., Lees A.J., and Wood N.W. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol. 54 (2003) 283-286
13. Hering R., Strauss K.M., Tao X., Bauer A., Woitalla D., Mietz E.-M., Petrovic S., Bauer P., Schaible W., Müller T., Schöls L., Klein C., Berg D., Meyer P.T., Schulz J.B., Wollnik B., Tong L., Krüger R., and Riess O. Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Hum. Mutat. 24 (2004) 321-329
14. Annesi G., Savettieri G., Pugliese P., D'Amelio M., Tarantino P., Ragonese P., La Bella V., Piccoli T., Civitelli D., Annesi F., Fierro B., Piccoli F., Arabia G., Caracciolo M., Ciro Candiano I.C., and Quattrone A. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann. Neurol. 58 (2005) 803-807
15. Hedrich K., Djarmati A., Schafer N., Hering R., Wellenbrock C., Weiss P.H., Hilker R., Vieregge P., Ozelius L.J., Heutink P., Bonifati V., Schwinger E., Lang A.E., Noth J., Bressman S.B., Pramstaller P.P., Riess O., and Klein C. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology 62 (2004) 389-394
16. van Duijn C.M., Dekker M.C., Bonifati V., Galjaard R.J., Houwing-Duistermaat J.J., Snijders P.J., Testers L., Breedveld G.J., Horstink M., Sandkuijl L.A., van Swieten J.C., Oostra B.A., and Heutink P. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am. J. Hum. Genet. 69 (2001) 629-634
17. Hague S., Rogaeva E., Hernandez D., Gulick C., Singleton A., Hanson M., Johnson J., Weiser R., Gallardo M., Ravina B., Gwinn-Hardy K., Crawley A., St George-Hyslop P.H., Lang A.E., Heutink P., Bonifati V., Hardy J., and Singleton A. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann. Neurol. 54 (2003) 271-274
18. Eerola J., Hernandez D., Launes J., Hellström O., Hague S., Gulick C., Johnson J., Peuralinna T., Hardy J., Tienari P.J., and Singleton A.B. Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD. Neurology 61 (2003) 1000-1002
19. Morris C.M., O'Brien K.K., Gibson A.M., Hardy J.A., and Singleton A.B. Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease. Neurosci. Lett. 352 (2003) 151-153
20. Klein C., and Schlossmacher M.G. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 69 (2007) 2093-2104
21. Dekker M., Bonifati V., van Swieten J., Leenders N., Galjaard R.J., Snijders P., Horstink M., Heutink P., Oostra B., and van Duijn C. Clinical features and neuroimaging of PARK7-linked parkinsonism. Mov. Disord. 18 (2003) 751-757
22. Dekker M.C.J., Eshuis S.A., Maguire R.P., Veenma-van der Duijn L., Pruim J., Snijders P.J.L.M., Oostra B.A., van Duijn C.M., and Leenders K.L. PET neuroimaging and mutations in the DJ-1 gene. J. Neural Transm. 111 (2004) 1575-1581
23. Schweitzer K.J., Brüssel T., Leitner P., Krüger R., Bauer P., Woitalla D., Tomiuk J., Gasser T., and Berg D. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. J. Neurol. 254 (2007) 613-616
24. Bandopadhyay R., Kingsbury A.E., Cookson M.R., Reid A.R., Evans I.M., Hope A.D., Pittman A.M., Lashley T., Canet-Avilés R., Miller D.W., McLendon C., Strand C., Leonard A.J., Abou-Sleiman P.M., Healy D.G., Ariga H., Wood N.W., de Silva R., Revesz T., Hardy J.A., and Lees A.J. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127 (2004) 420-430
25. Rizzu P., Hinkle D.A., Zhukareva V., Bonifati V., Severijnen L.-A., Martinez D., Ravid R., Kamphorst W., Eberwine J.H., Lee V.M.-Y., Trojanowski J.Q., and Heutink P. DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann. Neurol. 55 (2004) 113-118
26. Neumann M., Müller V., Görner K., Kretzschmar H.A., Haass C., and Kahle P.J. Pathological properties of the Parkinson's disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol. 107 (2004) 489-496
27. Mullett S.J., Hamilton R.L., and Hinkle D.A. DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age. Neuropathology 29 (2009) 125-131
28. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.-S., and Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281 (2006) 10816-10824
29. Terracciano C., Nogalska A., Engel W.K., Wojcik S., and Askanas V. In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized. Free Radic. Biol. Med. 45 (2008) 773-779
30. Honbou K., Suzuki N.N., Horiuchi M., Niki T., Taira T., Ariga H., and Inagaki F. The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J. Biol. Chem. 278 (2003) 31380-31384
31. Huai Q., Sun Y., Wang H., Chin L.-S., Li L., Robinson H., and Ke H. Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. FEBS Lett. 549 (2003) 171-175
32. Tao X., and Tong L. Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J. Biol. Chem. 278 (2003) 31372-31379
33. Wilson M.A., Collins J.L., Hod Y., Ringe D., and Petsko G.A. The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9256-9261
34. Martinat C., Shendelman S., Jonason A., Leete T., Beal M.F., Yang L., Floss T., and Abeliovich A. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary parkinsonism. PLoS Biol. 2 (2004) e327
35. Lee S.-J., Kim S.J., Kim I.-K., Ko J., Jeong C.-S., Kim G.-H., Park C., Kang S.-O., Suh P.-G., Lee H.-S., and Cha S.-S. Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J. Biol. Chem. 278 (2003) 44552-44559
36. Wilson M.A., St. Amour C.V., Collins J.L., Ringe D., and Petsko G.A. The 1.8-Å resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: a member of the DJ-1/ThiJ/PfpI superfamily. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1531-1536
37. Shendelman S., Jonason A., Martinat C., Leete T., and Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation. PLoS Biol. e362 (2004) 2
38. Zhou W., Zhu M., Wilson M.A., Petsko G.A., and Fink A.L. The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein. J. Mol. Biol. 356 (2006) 1036-1048
39. Abdallah J., Caldas T., Kthiri F., Kern R., and Richarme G. YhbO protects cells against multiple stresses. J. Bacteriol. 189 (2007) 9140-9144
40. Fioravanti E., Durá M.A., Lascoux D., Micossi E., Franzetti B., and McSweeney S. Structure of the stress response protein DR1199 from Deinococcus radiodurans: a member of the DJ-1 superfamily. Biochemistry 47 (2008) 11581-11589
41. Kinumi T., Kimata J., Taira T., Ariga H., and Niki E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 317 (2004) 722-728
42. a depression by a protonated glutamic acid in human DJ-1. Biochemistry 47 (2008) 7430-7440
43. Blackinton J., Lakshminarasimhan M., Thomas K.J., Ahmad R., Greggio E., Raza A.S., Cookson M.R., and Wilson M.A. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J. Biol. Chem. 284 (2009) 6476-6485
44. Canet-Avilés R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., and Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9103-9108
45. Waak J., Weber S.S., Görner K., Schall C., Ichijo H., Stehle T., and Kahle P.J. Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. J. Biol. Chem. 284 (2009) 14245-14257
46. Lakshminarasimhan M., Maldonado M.T., Zhou W., Fink A.L., and Wilson M.A. Structural impact of three Parkinsonism-associated missense mutations on human DJ-1. Biochemistry 47 (2008) 1381-1392
47. Malgieri G., and Eliezer D. Structural effects of Parkinson's disease linked DJ-1 mutations. Protein Sci. 17 (2008) 855-868
48. Görner K., Holtorf E., Waak J., Pham T.-T., Vogt-Weisenhorn D.M., Wurst W., Haass C., and Kahle P.J. Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1. J. Biol. Chem. 282 (2007) 13680-13691
49. Ramsey, C. P.; Giasson, B. I. The E163K DJ-1 mutant shows specific antioxidant deficiency. Brain Res. 1239:1-11; 2008.
50. Chen L., Cagniard B., Mathews T., Jones S., Koh H.C., Ding Y., Carvey P.M., Ling Z., Kang U.J., and Zhuang X. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J. Biol. Chem. 280 (2005) 21418-21426
51. Yamaguchi H., and Shen J. Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice. Mol. Neurodegener. 2 (2007) 10
52. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T.M., and Dawson V.L. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14807-14812
53. Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D., Lozano A.M., Anisman H., Park D.S., and Mak T.W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5215-5220
54. Manning-Bog A.B., Caudle W.M., Perez X.A., Reaney S.H., Paletzki R., Isla M.Z., Chou V.P., McCormack A.L., Miller G.W., Langston J.W., Gerfen C.R., and DiMonte D.A. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol. Dis. 27 (2007) 141-150
55. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M.M., Takahashi K., and Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5 (2004) 213-218
56. Goldberg M.S., Pisani A., Haburcak M., Vortherms T.A., Kitada T., Costa C., Tong Y., Martella G., Tscherter A., Martins A., Bernardi G., Roth B.L., Pothos E.N., Calabresi P., and Shen J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45 (2005) 489-496
57. Storch A., Ludolph A.C., and Schwarz J. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J. Neural Transm. 111 (2004) 1267-1286
58. Aleyasin H., Rousseaux M.W.C., Phillips M., Kim R.H., Bland R.J., Callaghan S., Slack R.S., During M.J., Mak T.W., and Park D.S. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 18748-18753
59. Yanagisawa D., Kitamura Y., Inden M., Takata K., Taniguchi T., Morikawa S., Morita M., Inubushi T., Tooyama I., Taira T., Iguchi-Ariga S.M.M., Akaike A., and Ariga H. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J. Cereb. Blood Flow Metab. 28 (2008) 563-578
60. Inden M., Taira T., Kitamura Y., Yanagida T., Tsuchiya D., Takata K., Yanagisawa D., Nishimura K., Taniguchi T., Kiso Y., Yoshimoto K., Agatsuma T., Koide-Yoshida S., Iguchi-Ariga S.M.M., Shimohama S., and Ariga H. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol. Dis. 24 (2006) 144-158
61. Paterna J.-C., Leng A., Weber E., Feldon J., and Büeler H. DJ-1 and parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol. Ther. 15 (2007) 698-704
62. Bai Q., Mullett S.J., Garver J.A., Hinkle D.A., and Burton E.A. Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Res. 1113 (2006) 33-44
63. Baulac S., Lu H., Strahle J., Yang T., Goldberg M.S., Shen J., Schlossmacher M.G., Lemere C.A., Lu Q., and Xia W. Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol. Neurodegener. 4 (2009) 12
64. Bretaud-Marsollier S., Allen C., Ingham P.W., and Bandmann O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. 100 (2007) 1626-1635
65. Menzies F.M., Yenisetti S.C., and Min K.-T. Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr. Biol. 15 (2005) 1578-1582
66. Meulener M., Whitworth A.J., Armstrong-Gold C.E., Rizzu P., Heutink P., Wes P.D., Pallanck L.J., and Bonini N. M. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 15 (2005) 1572-1577
67. Park J., Kim S.Y., Cha G.H., Lee S.B., Kim S., and Chung J. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361 (2005) 133-139
68. Yang Y., Gehrke S., Haque M.E., Imai Y., Kosek J., Yang L., Beal M.F., Nishimura I., Wakamatsu K., Ito S., Takahashi R., and Lu B. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13670-13675
69. Vasseur S., Afzal S., Tardivel-Lacombe J., Park D.S., Iovanna J.L., and Mak T.W. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 1111-1116
70. Meulener M.C., Xu K., Thomson L., Ischiropoulos H., and Bonini N.M. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12517-12522
71. Bandyopadhyay S., and Cookson M.R. Evolutionary and functional relationships within the DJ1 superfamily. BMC Evol. Biol. 4 (2004) 6
72. Ved R., Saha S., Westlund B., Perier C., Burnam L., Sluder A., Hoener M., Rodrigues C.M.P., Alfonso A., Steer C., Liu L., Przedborski S., and Wolozin B. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of α-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J. Biol. Chem. 280 (2005) 42655-42668
73. Yamazaki H., Tomono A., Ohnishi Y., and Horinouchi S. DNA-binding specificity of AdpA, a transcriptional activator in the A-factor regulatory cascade in Streptomyces griseus. Mol. Microbiol. 53 (2004) 555-572
74. Quigley P.M., Korotkov K., Baneyx F., and Hol W.G.J. The 1.6-Å crystal structure of the class of chaperones represented by Escherichia coli Hsp31 reveals a putative catalytic triad. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3137-3142
75. Wilson M.A., Ringe D., and Petsko G.A. The atomic resolution crystal structure of the YajL (ThiJ) protein from Escherichia coli: a close prokaryotic homologue of the Parkinsonism-associated protein DJ-1. J. Mol. Biol. 353 (2005) 678-691
76. Klinefelter G.R., Welch J.E., Perreault S.D., Moore H.D., Zucker R.M., Suarez J.D., Roberts N.L., Bobseine K., and Jeffay S. Localization of the sperm protein SP22 and inhibition of fertility in vivo and in vitro. J. Androl. 23 (2002) 48-63
77. Wagenfeld A., Gromoll J., and Cooper T.G. Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization. Biochem. Biophys. Res. Commun. 251 (1998) 545-549
78. Welch J.E., Barbee R.R., Roberts N.L., Suarez J.D., and Klinefelter G.R. SP22: a novel fertility protein from a highly conserved gene family. J. Androl. 19 (1998) 385-393
79. Lev N., Ickowicz D., Melamed E., and Offen D. Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology 29 (2008) 397-405
80. Li H.M., Niki T., Taira T., Iguchi-Ariga S.M.M., and Ariga H. Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress. Free Radic. Res. 39 (2005) 1091-1099
81. Junn E., Jang W.H., Zhao X., Jeong B.S., and Mouradian M.M. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J. Neurosci. Res 87 (2009) 123-129
82. Jin J., Li G.J., Davis J., Zhu D., Wang Y., Pan C., and Zhang J. Identification of novel proteins associated with both α-synuclein and DJ-1. Mol. Cell. Proteomics 6 (2007) 845-859
83. Junn E., Taniguchi H., Jeong B.S., Zhao X., Ichijo H., and Mouradian M.M. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc. Natl. Acad. Sci. USA 102 (2005) 9691-9696
84. Mo J.-S., Kim M.-Y., Ann E.-J., Hong J.-A., and Park H.-S. DJ-1 modulates UV-induced oxidative stress signaling through the suppression of MEKK1 and cell death. Cell Death Differ. 15 (2008) 1030-1041
85. Niki T., Takahashi-Niki K., Taira T., Iguchi-Ariga S.M.M., and Ariga H. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol. Cancer Res. 1 (2003) 247-261
86. 2-induced cell death. Free Radic. Res. 40 (2006) 155-165
87. Shinbo Y., Taira T., Niki T., Iguchi-Ariga S.M.M., and Ariga H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int. J. Oncol 26 (2005) 641-648
88. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M.M., and Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor. J. Biol. Chem 276 (2001) 37556-37563
89. Xu J., Zhong N., Wang H., Elias J.E., Kim C.Y., Woldman I., Pifl C., Gygi S.P., Geula C., and Yankner B.A. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum. Mol. Genet. 14 (2005) 1231-1241
90. Zucchelli S., Vilotti S., Calligaris R., Lavina Z.S., Biagioli M., Foti R., De Maso L., Pinto M., Gorza M., Speretta E., Casseler C., Tell G., Del Sal G., and Gustincich S. Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death Differ. 16 (2009) 428-438
91. Hod Y., Pentyala S.N., Whyard T.C., and El-Maghrabi M.R. Identification and characterization of a novel protein that regulates RNA-protein interaction. J. Cell. Biochem. 72 (1999) 435-444
92. van der Brug M.P., Blackinton J., Chandran J., Hao L.-Y., Lal A., Mazan-Mamczarz K., Martindale J., Xie C., Ahmad R., Thomas K.J., Beilina A., Gibbs J.R., Ding J., Myers A.J., Zhan M., Cai H., Bonini N.M., Gorospe M., and Cookson M.R. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 10244-10249
93. Zhou W., and Freed C.R. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 280 (2005) 43150-43158
94. Nishinaga H., Takahashi-Niki K., Taira T., Andreadis A., Iguchi-Ariga S.M.M., and Ariga H. Expression profiles of genes in DJ-1-knockdown and L 166 P DJ-1 mutant cells. Neurosci. Lett. 390 (2005) 54-59
95. Zhong N., and Xu J. Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1α: regulation by SUMOylation and oxidation. Hum. Mol. Genet. 17 (2008) 3357-3367
96. Clements C.M., McNally R.S., Conti B.J., Mak T.W., and Ting J.P.-Y. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 15091-15096
97. Tillman J.E., Yuan J., Gu G., Fazli L., Ghosh R., Flynt A.S., Gleave M., Rennie P.S., and Kasper S. DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Res 67 (2007) 4630-4637
98. Jeong H., Kim M.-S., Kwon J., Kim K.-S., and Seol W. Regulation of the transcriptional activity of the tyrosine hydroxylase gene by androgen receptor. Neurosci. Lett. 396 (2006) 57-61
99. Saeed U., Karunakaran S., Meka D.P., Koumar R.C., Ramakrishnan S., Joshi S.D., Nidadavolu P., and Ravindranath V. Redox activated MAP kinase death signaling cascade initiated by ASK1 is not activated in female mice following MPTP: novel mechanism of neuroprotection. Neurotoxicol. Res. 16 (2009) 116-126
100. Taira T., Iguchi-Ariga S.M.M., and Ariga H. Co-localization with DJ-1 is essential for the androgen receptor to exert its transcription activity that has been impaired by androgen antagonists. Biol. Pharm. Bull. 27 (2004) 574-577
101. Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C., Seino C., Iguchi-Ariga S.M.M., and Ariga H. Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ. 13 (2006) 96-108
102. Fan J., Ren H., Fei E., Jia N., Ying Z., Jiang P., Wu M., and Wang G. Sumoylation is critical for DJ-1 to repress p53 transcriptional activity. FEBS Lett. 582 (2008) 1151-1156
103. Fan J., Ren H., Jia N., Fei E., Zhou T., Jiang P., Wu M., and Wang G. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J. Biol. Chem. 283 (2008) 4022-4030
104. Zhong N., Kim C.Y., Rizzu P., Geula C., Porter D.R., Pothos E.N., Squitieri F., Heutink P., and Xu J. DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J. Biol. Chem. 281 (2006) 20940-20948
105. Blackinton J., Ahmad R., Miller D.W., van der Brug M.P., Canet-Avilés R.M., Hague S.M., Kaleem M., and Cookson M.R. Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. Mol. Brain Res. 134 (2005) 76-83
106. Zhang L., Shimoji M., Thomas B., Moore D.J., Yu S.W., Marupudi N.I., Torp R., Torgner I.A., Ottersen O.P., Dawson T.M., and Dawson V.L. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14 (2005) 2063-2073
107. Ooe H., Taira T., Iguchi-Ariga S.M.M., and Ariga H. Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol. Sci. 88 (2005) 114-126
108. Exner N., Treske B., Paquet D., Holmström K., Schiesling C., Gispert S., Carballo-Carbajal I., Berg D., Hoepken H.H., Gasser T., Krüger R., Winklhofer K.F., Vogel F., Reichert A.S., Auburger G., Kahle P.J., Schmid B., and Haass C. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27 (2007) 12413-12418
109. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J.W., Yang L., Beal M.F., Vogel H., and Lu B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by parkin. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10793-10798
110. Krebiehl G., Ruckerbauer S., Schiesling C., Waak J., Wolburg H., Riess O., Kahle P.J., Proikas-Cezanne T., and Krüger R. Characterization of a mitochondrial phenotype caused by loss of Parkinson's disease associated DJ-1 protein. Soc. Neurosci. Abstr. 832 (2008) 820
111. Dodson M.W., and Guo M. Pink1, parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr. Opin. Neurobiol. 17 (2007) 331-337
112. Takahashi-Niki K., Niki T., Taira T., Iguchi-Ariga S.M.M., and Ariga H. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem. Biophys. Res. Commun. 320 (2004) 389-397
113. Duan X., Kelsen S.G., and Merali S. Proteomic analysis of oxidative stress-responsive proteins in human pneumocytes: insight into the regulation of DJ-1 expression. J. Proteome Res. 7 (2008) 4955-4961
114. Lev N., Ickowicz D., Barhum Y., Lev S., Melamed E., and Offen D. DJ-1 protects against dopamine toxicity. J. Neural Transm. 116 (2009) 151-160
115. Gu L., Cui T., Fan C., Zhao H., Zhao C., Lu L., and Yang H. Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress. Biochem. Biophys. Res. Commun. 383 (2009) 469-474
116. Maher P., and Schubert D. Signaling by reactive oxygen species in the nervous system. Cell. Mol. Life Sci. 57 (2000) 1287-1305
117. Janssen-Heininger Y.M., Mossman B.T., Heintz N.H., Forman H.J., Kalyanaraman B., Finkel T., Stamler J.S., Rhee S.G., and van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 45 (2008) 1-17
118. Matsuzawa A., and Ichijo H. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 1780 (2008) 1325-1336
119. Waak J., Weber S.S., Waldenmaier A., Görner K., Alunni-Fabbroni M., Schell H., Vogt-Weisenhorn D., Pham T.T., Reumers V., Baekelandt V., Wurst W., and Kahle P.J. Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB J. 23 (2009) 2478-2489
120. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., Koyasu S., Matsumoto K., Takeda K., and Ichijo H. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6 (2005) 587-592
121. Mullett S.J., and Hinkle D.A. DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone. Neurobiol. Dis. 33 (2009) 28-36
122. Miyazaki, S.; Yanagida, T.; Nunome, K.; Ishikawa, S.; Inden, M.; Kitamura, Y.; Nakagawa, S.; Taira, T.; Hirota, K.; Niwa, M.; Iguchi-Ariga, S. M. M.; Ariga, H. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. J. Neurochem. 105:2418-2434; 2008.
123. Qu W., Fan L., Kim Y., Ishikawa S., Iguchi-Ariga S.M.M., Pu X.-P., and Ariga H. Kaempferol derivatives prevent oxidative stress-induced cell death in a DJ-1-dependent manner. J. Pharmacol. Sci. 110 (2009) 191-200
124. Macedo M.G., Verbaan D., Fang Y., van Rooden S.M., Visser M., Anar B., Uras A., Groen J.L., Rizzu P., van Hilten J.J., and Heutink P. Genotypic and ph enotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov. Disord. 24 (2009) 196-203